EY helps clients create long-term value for all stakeholders. Enabled by data and technology, our services and solutions provide trust through assurance and help clients transform, grow and operate.
At EY, our purpose is building a better working world. The insights and services we provide help to create long-term value for clients, people and society, and to build trust in the capital markets.
Dr. Chris Behrenbruch is the Managing Director and Group CEO of Telix Pharmaceuticals. With over two decades of experience in radiopharmaceuticals and biotech, he holds a DPhil in biomedical engineering from the University of Oxford, an executive MBA jointly awarded from New York University, HEC Paris and the London School of Economics (TRIUM Program), and a Juris Doctor from the University of Melbourne. He has led multiple global healthcare ventures and champions purpose-driven leadership.